Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efpeglenatide versus placebo in type 2 diabetes patients inadequately controlled with metformin (±sulfonylurea) was terminated; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• efpeglenatide (efpeglenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-12-02